PHIA Koninklijke Philips N.V.

Philips Future Health Index 2023 global report: healthcare leaders focused on addressing staff shortages, with the support of more AI investments

Philips Future Health Index 2023 global report: healthcare leaders focused on addressing staff shortages, with the support of more AI investments

April 18, 2023

  • Healthcare leaders are heavily investing in AI or plan to do so for both critical decision support and operational efficiency, helping tackle staff shortages
  • Largest global survey of its kind shows healthcare leaders continue to recognize virtual care as key to bringing care closer to patients, wherever they are

Amsterdam, the Netherlands, and Chicago, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of its : Taking healthcare everywhere. Unveiled at , the eighth annual FHI 2023 global report shows healthcare leaders are increasingly prepared to invest in AI, recognize the opportunity virtual care offers to bring care closer to patients, and acknowledge the importance of building partnerships to improve care.

“Post Covid, demand for healthcare services has increased, but there are fewer healthcare professionals available to serve this growing number of patients. This year’s report shows healthcare leaders are prepared to invest in AI to alleviate this pressure on their workforce,” said , Chief Innovation & Strategy Officer and Business Leader of Enterprise Informatics at Philips. “In order to genuinely relieve that burden, it’s essential that new AI capabilities are interoperable and embedded into clinical and operational workflows.”

Tackling staff shortages with digital innovation and automation

Planned investments in AI over the next three years show the biggest increase in critical decision support (39% in 2023, up from 24% in 2021). This was a top choice among cardiology (50%) and radiology (48%) leaders. The percentage of healthcare leaders planning to invest in AI for operational efficiency, including automating documentation, scheduling patients, and performing routine tasks, remained steady at 37%.

Bringing care closer to the patient, expanding access points and convenience

With moving care to new settings a key contributor to reducing staffing pressure, 70% of all respondents say virtual care has had the biggest impact on improving patient care or will in the next three years. The report also shows virtual care is moving into more areas of care, meeting patients where they are. 82% of healthcare leaders say that their facility currently provides intensive or critical care supported virtually (41%) or plans to in the next three years (41%). Virtual care also plays a vital role in attracting and retaining talent, with 44% of younger healthcare professionals indicating new care delivery models that connect different care settings are a top priority when choosing where to work.

Partnering across the healthcare ecosystem to expand the reach of care

One in three (34%) healthcare leaders are building partnerships outside their healthcare system to be able to provide the best possible care. Among their top choices of current partners are diagnostic imaging or screening centers (28%), ambulatory care centers (23%), emergency medical centers (23%), and retailers or pharmacies (22%) – all of which can also help in bringing care closer to the patient.

The FHI 2023 report is based on proprietary research among nearly 3,000 healthcare leaders and younger healthcare professionals conducted in 14 countries. To access the report, visit .

For further information, please contact:



Meredith Amoroso

Philips Global Press Office

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments



EN
18/04/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips expands digital pathology portfolio with cloud-enabled Philips...

Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite March 11, 2026 Fully cloud‑enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Amsterdam, The Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its digital pathology portfolio with new cloud-enabled capabilities designed to help healthcare organizations scale digital diagnostics, improve productivity, and advance their transformation to fully digital workflows....

 PRESS RELEASE

Philips connects patient monitoring and diagnostics to advance platfor...

Philips connects patient monitoring and diagnostics to advance platform-based care intelligence at HIMSS26 March 10, 2026 Amsterdam, the Netherlands, and Las Vegas, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how open, interoperable, AI-enabled platforms can help health systems connect continuous patient monitoring with diagnostic insights – bringing the patient story together across time and across specialties. By connecting clinical signals with diagnostic information, Philips enables care teams to move from fragmented data to a more continuous,...

Marc Hesselink ... (+2)
  • Marc Hesselink
  • CFA

Philips/Execution is key/HOLD

Philips reported a better-than-expected 4Q25 update and a supportive CMD message. We increase our estimates, raise our target price from €23 to €26 and reiterate our Hold rating. Philips appears positioned to continue progressing operationally, but we believe consistent delivery will be required before we see meaningful outperformance versus the sector. Valuation at 15x adj EPS 2027F is in line with peers.

 PRESS RELEASE

Philips unveils Rembra CT at ECR 2026, setting a new benchmark for spe...

Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments March 4, 2026 CE Marked and 510(k) pending, Rembra’s advanced image reconstruction technology delivers up to 106 images per second [1] and a high throughput of up to 270 patients per day [2] to support faster diagnosis by making scans available in near-real timeWith the largest-in-class 85 cm bore, Rembra accommodates challenging patient types, providing more access for complex interventions, bariatric imaging a...

 PRESS RELEASE

Philips publishes its Annual Report 2025

Philips publishes its Annual Report 2025 February 19, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025. Philips’ Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. The convocation notice and the agenda, including explanatory notes, for the AGM will be published in due course. Philips filed the Annual Report 2025 with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF) and expects to f...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch